AstraZeneca Pharma India informs about disclosure

04 Dec 2024 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed that the Company has received an order from the Income-tax Appellate Tribunal (‘ITAT’) issued under section 254 of the Income Tax Act, 1961 for the assessment year 2017-18 and 2018-19 on December 3, 2024. In this regard, the company has enclosed the details as required under the SEBI Circular SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 attached as Annexure – A.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8606.35 112.45 (1.32%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...